默沙东2024年HPV疫苗收入掉头向下 中国市场需求缩减,暂停发货至少到年中

每日经济新闻
07 Feb

每经记者:陈星每经编辑:董兴生近日,默沙东宣布将暂停向中国市场供应佳达修HPV宫颈癌疫苗,此次供应暂停将至少持续至2025年年中,原因是中国市场对HPV疫苗需求疲弱,为加速库存消耗而暂时向中国市场停止发货。在同日发布的2024年第四季度财报及去年全年业绩报告中,默沙东透露,其第四季度实现了156亿美元的销售额,与前一年同期相比增长7%。然而,佳达修的销售额却出现了下滑,同比下降17%,为15.5...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10